Related Experiment Video
Updated: Feb 21, 2026

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
Published on: October 5, 2018
Effect of potassium channel openers in acute and chronic models of glaucoma
Shital S Panchal1, Anita A Mehta2, Devdas D Santani3
1Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India.
Purpose:
Glaucoma is characterized by increased intraocular pressure (IOP). The effect of nicorandil and pinacidil on IOP in experimentally induced acute and chronic models of glaucoma and the mechanism of action involved were studied.
Methods:
New Zealand white rabbits were used for the study. After the measurement of IOP, nicorandil (1%), pinacidil (1%), and pilocarpine as standard (1%) were instilled topically into the left eye. The other eye served as control. Dextrose (5%) was used to induce acute glaucoma. IOP changes were recorded every 15 minutes until the pressure became normal. Freshly prepared α-chymotrypsin solution was introduced in the posterior chamber to induce chronic glaucoma. Rabbits with ocular hypertension were selected for the study. Similar drug solutions were used to study the effect on IOP. Glibenclamide, pilocarpine, and indomethacin (1%) were used to study the mechanism of action of both drugs. The IOPs were measured just prior to drug instillation and at suitable time intervals using a tonometer.
Results:
Pretreatment with topical nicorandil and pinacidil significantly lowered the rise in IOP in the acute model. Nicorandil and pinacidil initially caused rise in IOP for 15-30 minutes in chronic glaucoma. This was followed by reduction in IOP. Pretreatment with indomethacin and pilocarpine did not modify the effect of nicorandil and pinacidil on IOP. Pretreatment with glibenclamide blocked IOP from the lowering effect of nicorandil and pinacidil.
Conclusion:
The oculohypotensive effect shown by these drugs appears to be attributable to enhancement of the aqueous humor outflow. This effect is perhaps mediated through potassium channels.
Insights
Nicorandil and pinacidil effectively lowered intraocular pressure (IOP) in glaucoma models. Their oculohypotensive effect, likely mediated by potassium channels, enhances aqueous humor outflow.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma is a leading cause of irreversible blindness, characterized by elevated intraocular pressure (IOP).
- Understanding the mechanisms and therapeutic agents for IOP reduction is crucial for glaucoma management.
Purpose of the Study:
- To investigate the effects of nicorandil and pinacidil on intraocular pressure (IOP) in experimental acute and chronic glaucoma models.
- To elucidate the mechanism of action underlying the IOP-modulating effects of these agents.
Main Methods:
- Topical administration of nicorandil (1%), pinacidil (1%), and pilocarpine (1%) in New Zealand white rabbits.
- Induction of acute glaucoma using dextrose (5%) and chronic glaucoma using α-chymotrypsin.
- Measurement of IOP at regular intervals using a tonometer.
- Investigating drug mechanisms using glibenclamide, pilocarpine, and indomethacin.
Main Results:
- Nicorandil and pinacidil significantly reduced IOP in acute glaucoma models.
- In chronic glaucoma, these drugs initially increased IOP (15-30 min) before causing a sustained reduction.
- Glibenclamide pretreatment blocked the IOP-lowering effect, suggesting involvement of ATP-sensitive potassium channels.
Conclusions:
- The oculohypotensive effect of nicorandil and pinacidil is likely mediated by enhancing aqueous humor outflow.
- Potassium channels appear to play a significant role in the mechanism of action for these drugs in reducing IOP.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antihypertensive Drugs: Potassium-Sparing Diuretics
G-Protein Gated Ion Channels
Sensory...

